Skip to main content
    H

    Harvard Bioscience Inc (HBIO)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $8.91
    -0.48 (-5.11%)

    Market Cap: $42.94M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Harvard Bioscience Inc (HBIO) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Harvard Bioscience are Daxor (DXR), Nephros (NEPH) and Precision Optics Corporation, Inc. Common stock (POCI). By market cap, Harvard Bioscience ranks 8th of the 13 companies on this page; Anbio Biotechnology Class A Ordinary Shares (NNNN) is the largest at $167.66M.

    Peer Comparison

    HBIO's ROIC of -10.2% is above the peer median of -20.2%, and its revenue growth of 7.8% is below the median of 18.8%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Harvard Bioscience (HBIO)$42.94MN/A0.5x-13.2%-10.2%7.8%0.00%
    Daxor Corporation (DXR)$49.51MN/A266.9x19861.0%N/A25.5%0.00%
    Nephros Inc (NEPH)$33.15M23.1x1.5x8.8%10.8%18.0%0.00%
    Precision Optics Corporation, Inc. Common stock (POCI)$57.50MN/A1.7x-11.5%-9.0%42.0%0.00%
    Milestone Scientific (MLSS)$27.82MN/A3.0x-44.0%N/A22.3%0.00%
    ZEN Graphene Solutions Ltd (ZTEK)$62.30MN/AN/A0.0%N/A-95.5%0.00%
    Stereotaxis Inc (STXS)$85.02MN/A2.6x-70.9%-62.4%19.6%0.00%
    Retractable Technologies Inc (RVP)$16.76MN/A0.4x-9.9%-31.4%-31.1%0.00%
    Anbio Biotechnology Class A Ordinary Shares (NNNN)$167.66MN/A19.7x74.1%N/A73.9%0.00%
    Safeplus International Holdings Limited (BIPH)$357540N/A0.3x0.0%N/A17.1%8.62%
    Femasys Inc (FEMY)$11.89MN/A5.6x0.0%-40.0%-18.9%0.00%
    Heron Therapeuti (HRTX)$59.08MN/A0.4x-14.5%-8.4%-7.8%0.00%
    iBio, Inc. Common Stock (IBIO)$51.55MN/A735.4x0.0%N/A975.0%0.00%
    Peer median$50.53M23.1x2.6x0.0%-20.2%18.8%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Harvard Bioscience, ranked by how closely their business, size, sector and industry match. The largest group, 10 of the 12, is in Medical Instruments & Supplies; the other 2 are in Biotechnology.

    CompanyAboutPeers
    Daxor Corporation (DXR)Medical Instruments & Supplies
    Daxor Corporation, a medical device company, provides cryobank and biotechnology services in the United States.
    Nephros Inc (NEPH)Medical Instruments & Supplies
    Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States.
    NEPH competitors
    Precision Optics Corporation, Inc. Common stock (POCI)Medical Instruments & Supplies
    Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and lighting systems and related components primarily...
    POCI competitors
    Milestone Scientific (MLSS)Medical Instruments & Supplies
    Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States, China...
    MLSS competitors
    ZEN Graphene Solutions Ltd (ZTEK)Medical Instruments & Supplies
    ZEN Graphene Solutions Ltd (ZTEK) is an innovative leader in the materials technology sector...
    Stereotaxis Inc (STXS)Medical Instruments & Supplies
    Stereotaxis, Inc. designs, manufactures, and markets robotic magnetic navigation (MRI) systems for use in the hospital's interventional operating room...
    STXS competitors
    Retractable Technologies Inc (RVP)Medical Instruments & Supplies
    Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United...
    RVP competitors
    Anbio Biotechnology Class A Ordinary Shares (NNNN)Medical Instruments & Supplies
    Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa...
    Safeplus International Holdings Limited (BIPH)Medical Instruments & Supplies
    Biophan Technologies, Inc. develops and markets various technologies for the medical device industries. The company is headquartered in Pittsford, New York.
    Femasys Inc (FEMY)Medical Instruments & Supplies
    Femasys Inc. is a pioneering medical technology company focused on revolutionizing women's healthcare with its proprietary...
    FEMY competitors
    Heron Therapeuti (HRTX)Biotechnology
    Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs.
    HRTX competitors
    iBio, Inc. Common Stock (IBIO)Biotechnology
    iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States.
    IBIO competitors

    Frequently Asked Questions About HBIO

    Who are Harvard Bioscience's main competitors?

    The companies most similar to Harvard Bioscience include Daxor (DXR), Nephros (NEPH), Precision Optics Corporation, Inc. Common stock (POCI), Milestone Scientific (MLSS) and ZEN Graphene Solutions (ZTEK), listed from the closest match.

    Who is Harvard Bioscience's biggest competitor?

    Anbio Biotechnology Class A Ordinary Shares (NNNN) is the largest of the similar companies at $167.66M; Daxor (DXR) is the closest match by business profile, size, sector and industry.

    How does HBIO stock compare with its competitors?

    HBIO's P/S is 0.5x against a peer median of 2.6x; its net margin is -13.2% against a peer median of 0.0%.

    Which of Harvard Bioscience's competitors pays a higher dividend?

    Harvard Bioscience pays no dividend. Safeplus International Holdings (BIPH) has a higher forward dividend yield; Safeplus International Holdings (BIPH) has the highest at 8.62%.

    Is Harvard Bioscience bigger than its competitors?

    No. Harvard Bioscience is 8th by market cap among the 13 companies on this page; the largest is Anbio Biotechnology Class A Ordinary Shares (NNNN) at $167.66M.